Yokogawa leverages ICQ to bring bioreactors to U.S. Yokogawa Electric has entered into a partnership with Integrated Commissioning and Qualification Consultants (ICQ) in which ICQ will provide consulting and engineering services for the installation, maintenance, qualification, and support of Yokogawa's bioreactor systems and related products in the U.S.Read More
Aridis moves forward with COVID-19 inhaled antibody development Anti-infective therapies firm Aridis Pharmaceuticals said that it has augmented its inhaled AR-711 monoclonal antibody to COVID-19 with a second monoclonal antibody designed to neutralize newly emerging COVID-19 mutated variants.Read More
New technique detects unique folding patterns in RNA of SARS-CoV-2 Scientists have developed a new technique for determining alternative structural RNA shapes of the SARS-CoV-2 virus. These self-regulatory segments of RNA, called switches, could serve as potential antiviral drug targets, according to a communication published in Nature Methods on February 22.Read More
Biohaven's antiviral antibody conjugate is effective in vitro Biohaven Pharmaceutical's hyperimmune globulin mimic, developed on its proprietary multimodal antibody therapy enhancer platform, has demonstrated functional binding and neutralization of the SARS-CoV-2 virus, including emerging variants.Read More
Novavax to supply Covax with 1.1B COVID-19 vaccine doses Novavax announced a memorandum of understanding with Gavi, the Vaccine Alliance, to provide 1.1 billion cumulative doses of its COVID-19 vaccine candidate, NVX-CoV2373, to the Covax facility. The company has also fully enrolled participants in its pivotal phase III clinical trial of NVX-CoV2373.Read More
Thermo Fisher launches new electron microscope Thermo Fisher Scientific has unveiled its new Helios 5 PXL Wafer DualBeam, a plasma-focused ion beam scanning electron microscope. The microscope can reduce time-to-data from days to hours for inline through-stack metrology and verify high-aspect ratio structures, the firm said.Read More